Immune-mediated hemolytic anemia is a condition where the immune system attacks and destroys the body’s own red blood cells. This can rapidly lead to severe anemia, affect the liver and kidneys, and cause blood clots (i.e., thromboembolism) and other life-threatening complications. Primary IMHA, which represents the majority of cases in dogs, does not have an apparent cause. For secondary IMHA, possible immune system triggers include medications, blood parasites, tick-borne diseases, bee stings, snake bites, or cancer.

IMHA can have a high mortality rate during the first two weeks of treatment. Most dogs with IMHA will require hospitalization, blood transfusions, immunosuppressants, and antithrombotic medications. Refractory IMHA cases can require multiple blood transfusions, or surgery to remove the spleen. Any underlying disease should be identified and treated. Dogs will need medication for several months, with regular veterinary visits and diagnostic monitoring. Discussing a personalized management plan with your veterinarian is important for the best outcome for your dog.
The prognosis for dogs with IMHA depends on their condition at the time of diagnosis and their treatment response. After the initial crisis, up to 75% of dogs with IMHA can have a good quality and length of life. However, there is a 15% chance of relapse in the first five years.
Contact your veterinarian immediately if your dog becomes lethargic, is unable to walk, has abnormal gum color or difficulty breathing, or suddenly collapses.
Before your dog‘s condition becomes unmanageable, or they begin losing their quality of life, beginning end-of-life care discussions is vital. Learn more about pet hospice, in-home euthanasia, and our teleadvice service, or contact a Lap of Love veterinarian in your area, so you can feel fully prepared for this difficult time.